ProfileGDS5822 / ILMN_1225594
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 96% 94% 92% 96% 93% 93% 95% 93% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11355.696
GSM1276600PDAC Late Ablation Control 2877.794
GSM1276601PDAC Late Ablation Control 3754.492
GSM1276602PDAC Late Ablation 1130896
GSM1276603PDAC Late Ablation 2856.993
GSM1276604PDAC Late Ablation 3943.893
GSM1303940PDAC Late Ablation_anti-CTLA4 11203.995
GSM1303941PDAC Late Ablation_anti-CTLA4 2965.493
GSM1303942PDAC Late Ablation_anti-CTLA4 31022.694